Stay updated on Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Sign up to get notified when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.

Latest updates to the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page
- Check6 days agoChange DetectedLakefront Biotherapeutics NV has been added to the Collaborators and Investigators section, and Galapagos NV has been removed. This reflects changes in collaboration and may affect attribution and the points of contact for the trial.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, reflecting a software/template update rather than a change to the study details or content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision from v3.5.2 to v3.5.3 indicates a small update to the page version. There is no visible change to the study details or content shown in the provided data.SummaryDifference0.0%

- Check34 days agoChange DetectedUpdated the displayed collaborator name formatting from **“Ono Pharmaceutical Co. Ltd”** to **“Ono Pharmaceutical Co., Ltd.”**SummaryDifference0.0%

- Check42 days agoChange DetectedRevision tag updated from v3.5.0 to v3.5.2; no substantive changes to the study details or navigation are evident.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.0 was added; 'Sjogren's Syndrome' resources were removed and the prior Revision: v3.4.3 marker was deleted.SummaryDifference0.1%

Stay in the know with updates to Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib, Lanraplenib & Tirabrutinib in Sjogren's Clinical Trial page.